Print Friendly, PDF & Email

NCT/Study#

NCT04106167 /

FT-003

Long-Term, Non-Interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

DISEASE GROUP:

Phase 1 Clinical Trials

current phase:

NA

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587